ASXC News and Press, Asensus Surgical Inc Com From 12/19/22

RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that GPR Gesundhe...

Medical device company Asensus Surgical ( NYSE: ASXC ) has announced the sale of a Senhance Surgical System to the company's distribution partner in Germany. The digital laparoscopic platform will be placed at an end user oncology focused hospital. For further details see: ...

RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a Senhance ...

RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & ...

Asensus Surgical, Inc. (ASXC) Q3 2022 Results Conference Call November 10, 2022 04:30 PM ET Company Participants Mark Klausner - Investor Relations Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conferen...

Asensus Surgical ( NYSE: ASXC ) missed on the top line in its Q3 2022 financial results as revenue of $2.56M was a 0.4% year-over-year decline. Consensus estimate was $2.92M. Net loss in the quarter widened ~18% to $18.9M compared to the prior-year period (-$0.08 per s...

Asensus Surgical press release ( NYSE: ASXC ): Q3 Non-GAAP EPS of -$0.07. Revenue of $2.56M (-0.4% Y/Y). For further details see: Asensus Surgical Non-GAAP EPS of -$0.07, revenue of $2.56M

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operati...

First Hospital to Initiate a Senhance System Dedicated to Pediatric Procedures 9th Hospital in Germany to Utilize Senhance RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digit...

The following slide deck was published by Asensus Surgical, Inc. in conjunction with this event. For further details see: Asensus Surgical (ASXC) Investor Presentation - Slideshow